2.29
price down icon8.03%   -0.20
 
loading
Precedente Chiudi:
$2.49
Aprire:
$2.3
Volume 24 ore:
1.45M
Relative Volume:
1.73
Capitalizzazione di mercato:
$189.70M
Reddito:
$70.14M
Utile/perdita netta:
$-76.24M
Rapporto P/E:
-2.0631
EPS:
-1.11
Flusso di cassa netto:
$-57.06M
1 W Prestazione:
-21.58%
1M Prestazione:
-16.27%
6M Prestazione:
-26.13%
1 anno Prestazione:
-31.44%
Intervallo 1D:
Value
$2.22
$2.375
Intervallo di 1 settimana:
Value
$2.22
$3.0103
Portata 52W:
Value
$2.22
$6.08

Codexis Inc Stock (CDXS) Company Profile

Name
Nome
Codexis Inc
Name
Telefono
650-421-8100
Name
Indirizzo
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Name
Dipendente
188
Name
Cinguettio
@codexisinc
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
CDXS's Discussions on Twitter

Confronta CDXS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CDXS
Codexis Inc
2.29 189.70M 70.14M -76.24M -57.06M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 66.76B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Codexis Inc Stock (CDXS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-19 Downgrade The Benchmark Company Buy → Hold
2024-06-03 Ripresa Jefferies Buy
2024-05-30 Iniziato Cantor Fitzgerald Overweight
2024-02-29 Aggiornamento The Benchmark Company Hold → Buy
2023-11-07 Downgrade The Benchmark Company Buy → Hold
2023-08-07 Downgrade TD Cowen Outperform → Market Perform
2023-05-09 Downgrade H.C. Wainwright Buy → Neutral
2022-03-31 Ripresa Piper Sandler Overweight
2022-03-02 Ripresa Cowen Outperform
2021-04-12 Iniziato Piper Sandler Overweight
2021-03-01 Iniziato Stifel Buy
2021-02-26 Reiterato H.C. Wainwright Buy
2020-03-10 Iniziato The Benchmark Company Buy
2019-01-17 Aggiornamento First Analysis Sec Neutral → Outperform
2018-05-16 Iniziato Stephens Overweight
2017-10-13 Reiterato H.C. Wainwright Buy
2017-05-31 Iniziato Jefferies Buy
2017-01-26 Downgrade First Analysis Sec Overweight → Equal-Weight
2017-01-04 Aggiornamento Ladenburg Thalmann Neutral → Buy
2016-01-06 Iniziato H.C. Wainwright Buy
Mostra tutto

Codexis Inc Borsa (CDXS) Ultime notizie

pulisher
Apr 03, 2025

Codexis sees significant stock purchase by Opaleye Management, Inc. for $271,788 - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 02, 2025

Codexis stock hits 52-week low at $2.43 amid market challenges - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Protein Engineering Market Is Booming So Rapidly | Major Giants Merck KGaA, Agilent Technologies, Codexis - newstrail.com

Apr 02, 2025
pulisher
Apr 01, 2025

Codexis Appoints Cynthia Collins to Board of Directors - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

RNA Pioneer and Former Editas CEO Joins Codexis Board: Strategic Move for RNA Therapeutics Push - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Codexis appoints new independent board member By Investing.com - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

Charles Schwab Investment Management Inc. Purchases 26,052 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Codexis appoints new independent board member - Investing.com

Mar 31, 2025
pulisher
Mar 28, 2025

Codexis, Inc. (NASDAQ:CDXS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing - simplywall.st

Mar 28, 2025
pulisher
Mar 25, 2025

Codexis, Inc. (NASDAQ:CDXS) Holdings Increased by Bank of New York Mellon Corp - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Codexis sees $236,283 in stock purchases by Opaleye management - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Opaleye Management Inc. Expands Stake in Codexis Inc. - GuruFocus

Mar 24, 2025
pulisher
Mar 24, 2025

Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

New Contract Propels Codexis (CDXS) Stock Upward, Signaling Market Optimism - Stocks Telegraph

Mar 24, 2025
pulisher
Mar 24, 2025

Codexis Signs First Contract for ECO Synthesis Manufacturing Services -March 24, 2025 at 08:17 am EDT - MarketScreener

Mar 24, 2025
pulisher
Mar 24, 2025

Codexis Inc (NASDAQ: CDXS): Should Value Hunters Buy It? - Stocks Register

Mar 24, 2025
pulisher
Mar 24, 2025

Codexis Achieves Major Revenue Milestone: First ECO Synthesis Contract Signals Market Breakthrough - StockTitan

Mar 24, 2025
pulisher
Mar 21, 2025

Opaleye Management Inc. Increases Stake in Codexis Inc. - GuruFocus

Mar 21, 2025
pulisher
Mar 21, 2025

Codexis stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

Codexis stock hits 52-week low at $2.47 amid market challenges - Investing.com India

Mar 21, 2025
pulisher
Mar 14, 2025

Opaleye Management Inc. Boosts Investment in Codexis with Major Stock Purchase - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Cantor Fitzgerald Lowers Earnings Estimates for Codexis - Defense World

Mar 13, 2025
pulisher
Mar 11, 2025

Codexis sees $261,350 stock acquisition by Opaleye management - Investing.com Australia

Mar 11, 2025
pulisher
Mar 10, 2025

Codexis sees $261,350 stock acquisition by Opaleye management By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Stocks of Codexis Inc (CDXS) are poised to climb above their peers - SETE News

Mar 10, 2025
pulisher
Mar 10, 2025

Major Shareholder Makes Bold Move with Codexis Stock Purchase! - TipRanks

Mar 10, 2025
pulisher
Mar 09, 2025

Codexis Inc (CDXS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Advances - GuruFocus.com

Mar 09, 2025
pulisher
Mar 09, 2025

Rhumbline Advisers Boosts Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Codexis Announces New Employment Inducement Grants - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

Codexis grants equity to new hires under inducement plan - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

New Hires at Codexis Receive Significant Equity Compensation Package - StockTitan

Mar 07, 2025
pulisher
Mar 07, 2025

FY2025 EPS Estimates for Codexis Raised by Cantor Fitzgerald - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Codexis sees $172,273 stock purchase by Opaleye management - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Codexis sees $172,273 stock purchase by Opaleye management By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Things To Consider Before Buying Codexis Inc (NASDAQ: CDXS) - Stocks Register

Mar 06, 2025
pulisher
Mar 06, 2025

Codexis at TD Cowen Conference: Enzymatic Innovation in siRNA Manufacturing - Investing.com

Mar 06, 2025
pulisher
Mar 05, 2025

This trade activity should not be overlooked: Codexis Inc (CDXS) - SETE News

Mar 05, 2025
pulisher
Mar 05, 2025

Codexis stock touches 52-week low at $2.55 amid market challenges - Investing.com Australia

Mar 05, 2025
pulisher
Mar 03, 2025

Codexis Inc: Is CDXS Stock Worth Buying? - Stocks Register

Mar 03, 2025
pulisher
Mar 02, 2025

Investor Network: Codexis, Inc. to Host Earnings Call - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 02, 2025

Top 5 Synthetic Biology Public Companies (March 2025) - Securities.io

Mar 02, 2025
pulisher
Mar 01, 2025

Codexis (NASDAQ:CDXS investor three-year losses grow to 84% as the stock sheds US$93m this past week - Simply Wall St

Mar 01, 2025
pulisher
Mar 01, 2025

When Will Codexis, Inc. (NASDAQ:CDXS) Become Profitable? - Yahoo Finance UK

Mar 01, 2025
pulisher
Feb 28, 2025

Codexis Inc (CDXS) Q4 2024 Earnings Call Highlights: Strategic P - GuruFocus.com

Feb 28, 2025

Codexis Inc Azioni (CDXS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):